Rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolaemia: Economic analysis of the POLARIS study

被引：1
|
作者：
Miller, PSJ
Leiter, LA
Davies, A
Sosef, F
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Univ Toronto, Dept Med & Nutrit Sci, Toronto, ON, Canada
[3] Medtap Inc, London, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2005年 / 6卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(05)80451-9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] Rosuvastatin 40mg versus atorvastatin 80mg in high-risk patients with hypercholesterolaemia: Economic analysis of the POLARIS study
    Miller, PS
    Leiter, LA
    Davies, A
    Sosef, F
    VALUE IN HEALTH, 2005, 8 (06) : A103 - A103
  • [2] Rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolaemia: Early results of the POLARIS study
    Leiter, LA
    Palmer, M
    Kallend, D
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 113 - 113
  • [3] Rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolaemia: results of the POLARIS study at 8 and 26 weeks
    Leiter, L. A.
    Palmer, M.
    Sosef, F.
    EUROPEAN HEART JOURNAL, 2005, 26 : 581 - 581
  • [4] Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study
    Leiter, Lawrence A.
    Rosenson, Robert S.
    Stein, Evan
    Reckless, John P. D.
    Schulte, Karl-Ludwig
    Schleman, Margo
    Miller, Paul
    Palmer, Michael
    Sosef, Froukje
    ATHEROSCLEROSIS, 2007, 194 (02) : E154 - E164
  • [5] Efficacy of rosuvastatin 40 mg versus atorvastatin 80 mg in patients with the metabolic syndrome: results from a subgroup of the POLARIS study
    Leiter, LA
    Palmer, M
    Sosef, F
    DIABETOLOGIA, 2005, 48 : A392 - A392
  • [6] To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia
    Agrawal, Deepak
    Manchanda, S. C.
    Sawhney, J. P. S.
    Kandpal, Bhuwanesh
    Jain, Rajneesh
    Mehta, Ashwani
    Mohanty, Arun
    Passey, Rajiv
    Makhija, Aman
    Sharma, Manish Kr
    INDIAN HEART JOURNAL, 2018, 70 : S8 - S12
  • [7] Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia
    Wierzbicki, AS
    Lumb, PJ
    Chik, G
    Crook, MA
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (08) : 609 - 611
  • [8] Safety Outcomes of Atorvastatin 80 mg Versus Atorvastatin 40 mg in a Veteran Population
    Jacobs, Devon
    Wassell, Katelyn
    Guidry, Tommie Jo
    Sullivan, Joshua
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (02) : 151 - 156
  • [9] Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg
    Stein, Bradley
    Ward, Tiffany
    Hale, Genevieve
    Lyver, Elise
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 405 - 413
  • [10] Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia -: Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
    Clearfield, Michael B.
    Amerena, John
    Bassand, Jean-Pierre
    Hernandez Garcia, Hugo R.
    Miller, Sam S.
    Sosef, Froukje F. M.
    Palmer, Michael K.
    Bryzinski, Brian S.
    TRIALS, 2006, 7 (1)
12345